Essex Bio-Technology Limited (HKG:1061)

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Provision of Services	18.42M	11.54M	-	-	-
Provision of Services Growth	59.68%	-	-	-	-
Ophthalmology	771.49M	755.03M	553.56M	673.27M	419.23M
Ophthalmology Growth	2.18%	36.40%	-17.78%	60.60%	-26.13%
Surgical	879.90M	970.40M	764.15M	964.39M	558.89M
Surgical Growth	-9.33%	26.99%	-20.76%	72.56%	-21.50%
Total	1.67B	1.74B	1.32B	1.64B	978.11M
Total Growth	-3.87%	31.82%	-19.54%	67.43%	-23.55%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
People's Republic of China (The PRC)	1.66B	1.73B	1.32B	1.64B	978.11M
People's Republic of China (The PRC) Growth	-4.02%	31.43%	-19.54%	67.43%	-23.55%
Overseas	7.52M	5.10M	-	-	-
Overseas Growth	47.48%	-	-	-	-
Total	1.67B	1.74B	1.32B	1.64B	978.11M
Total Growth	-3.87%	31.82%	-19.54%	67.43%	-23.55%

Source: S&P Global Market Intelligence.